Please assess the completion status of the following clinical trial:

Trial Title: Low-dose Epinephrine Infusion Tests in Adolescent and Pediatric Patients

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Patients ages 3-18 years~2. Patients undergoing device closure of an atrial septal defect in the cardiac catheterization lab~3. normal electrocardiogram without prolonged absolute or corrected QT interval(less than 440 msec)~Exclusion Criteria:~1. Patients with a history of any other structural or acquired heart disease besides the atrial septal defect.~2. Patient with a family history of sudden cardiac death, or personal history of syncope.~3. Patient on alpha or beta-blocking medications.~4. Pregnancy.

- Gender: ALL
- Minimum Age: 3 Years
- Maximum Age: 18 Years
- Healthy Volunteers: f

Study Arms:
- Epinephrine (Type: EXPERIMENTAL): Healthy pediatric subjects will receive epinephrine. Epinephrine infusion will begin at 0.025 ug/kg/minute, for ten minutes.The epinephrine infusion will then be increased to 0.05 ug/kg/minute for five minutes. The epinephrine infusion will then be increased to a maximal dose of 0.1 ug/kg/minute for five minutes. The epinephrine infusion is then discontinued.

Based on this trial design, predict the completion outcome and termination type (if applicable).